Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05318417 · ClinicalTrials.gov registry record · NA
Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness
A NA study of Hearing Loss, Unilateral and Deafness, Unilateral, sponsored by Cochlear.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 8
- Study locations
NCT05318417 is a NA study of Hearing Loss, Unilateral and Deafness, Unilateral that is actively recruiting participants, run by Cochlear. The registered enrollment target is 60 participants, below the 3,477-participant average among 4 other Hearing Loss, Unilateral trials with a reported enrollment target (98% lower). The trial reports 8 study locations across 8 states.
The verdict
NCT05318417, a NA study of Hearing Loss, Unilateral and Deafness, Unilateral, is actively recruiting participants, sponsored by Cochlear.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 8
- Study locations
Study Summary
The aim of the study is to assess the continued efficacy and safety of cochlear implantation in participants aged 5 years and above with Unilateral Hearing Loss (UHL)/Single Sided Deafness (SSD) supporting a change indication for use.
Conditions Studied
Interventions
- DEVICE The Cochlear™ Nucleus® Cochlear Implant (CI) System
Study Locations (8)
California
- Stanford University - Palo Alto
Colorado
- Rocky Mountain Ear Center - Englewood
Iowa
- University of Iowa - Iowa City
New York
- New York Eye and Ear Infirmary - New York
North Carolina
- University of North Carolina - Chapel Hill
Ohio
- Nationwide Children's Hospital - Columbus
Texas
- University of Texas Southwestern Medical Center- Department of Otolaryngology Head and Neck Surgery - Dallas
Washington
- Virginia Mason Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-08-19 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05318417
The ClinicalTrials.gov registry entry for NCT05318417 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,477-participant average among 4 other Hearing Loss, Unilateral trials with a reported enrollment target (98% lower). The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hearing Loss, Unilateral appearing as the primary indexed condition, and to 1 intervention - of which The Cochlear™ Nucleus® Cochlear Implant (CI) System is the first listed.
NCT05318417 reports 8 study locations spanning 8 distinct geographic areas - top geographies include California, Colorado, Iowa.
Frequently Asked Questions
What is clinical trial NCT05318417 about?
NCT05318417 is a clinical study titled "Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness". The aim of the study is to assess the continued efficacy and safety of cochlear implantation in participants aged 5 years and above with Unilateral Hearing Loss (UHL)/Single Sided Deafness (SSD) supporting a change indication for use.
What is the current status of trial NCT05318417?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-08-19. Estimated completion is 2027-06.
What conditions does trial NCT05318417 study?
This clinical trial studies the following conditions: Hearing Loss, Unilateral, Deafness, Unilateral.
What interventions are being tested in trial NCT05318417?
The interventions under investigation include: The Cochlear™ Nucleus® Cochlear Implant (CI) System (DEVICE).
Who is sponsoring clinical trial NCT05318417?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05318417 being conducted?
This trial has 8 study locations across California, Colorado, Iowa, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Unilateral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.